skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
CMF Regimen (Code C63418)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Concept Status: Retired Concept  (See:  CMF Regimen )

Preferred Name: CMF Regimen

Definition: A chemotherapy regimen consisting of cyclophosphamide, methotrexate, and fluorouracil, which may be used in the adjuvant setting for the treatment of nonmetastatic breast cancer or alone for the treatment of metastatic breast cancer.

Label: CMF Regimen

NCI Thesaurus Code: C63418 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0055982  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
CMF Regimen
Cytoxan-Methotrexate-Fluorouracil Regimen

External Source Codes: 
PDQ Closed Trial Search ID 39060
PDQ Open Trial Search ID 39060 (check for NCI PDQ open clinical trial info)
UMLS CUI C0055982

Other Properties:
     Name Value (qualifiers indented underneath)
code C63418
Concept_Status Retired_Concept
deprecated true
DesignNote Source: NCCN Guidelines 2007 and PDQ
DesignNote Wed Sep 29 10:59:54 EDT 2010 - See 'Cyclophosphamide_Fluorouracil_Methotrexate'
Legacy_Concept_Name CMF_Regimen
OLD_PARENT Chemotherapy_Regimen_Used_to_Treat_Breast_Carcinoma
OLD_ROLE Chemotherapy_Regimen_Has_Component some Cyclophosphamide
OLD_ROLE Chemotherapy_Regimen_Has_Component some Fluorouracil
OLD_ROLE Chemotherapy_Regimen_Has_Component some Methotrexate
OLD_ROLE Regimen_Has_Accepted_Use_For_Disease some 'Breast Carcinoma'
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom